Interfering with lncRNA SNHG1 promotes the elevation of miR-448 levels, decreases IDO levels, and thus inhibits the differentiation of Treg cells and attenuates immune escape in breast cancer (75). The gene discussed is IDO1; the disease is breast cancer.